$AIZ

Assurant (AIZ) Lifted Its Outlook, Is The 13% Undervaluation Still There?

Assurant (AIZ) raised its full-year earnings outlook and plans to continue share repurchases. The stock has gained 20.20% year-to-date and 37.28% over one year. Analysts suggest it may be undervalued, with a fair value estimate of $330, citing growth in device protection subscribers and strong partnerships. However, risks include regulatory scrutiny and digital competition.

Original reporting
Published Sep 5, 2026, 10:27 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 6, 2026, 9:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AIZ
Bullish
medium confidence
Mentioned
$AIZ
Relevance
4/10
AlphAI data visualization · based on simplywall.st
Decision brief

The 30-second read

$AIZBullishLow
01

Why it matters

The article reiterates existing information without introducing fresh data, offering limited actionable insight.

02

Market read

Provides a recap of Assurant's earnings beat and outlook raise, with modest relevance for value‑focused traders.

03

What to watch

Potential regulatory scrutiny on lender‑placed products could cap upside.

Relevance 4/10Novelty 2/10Timing: post‑earnings recap

Background

The piece is a general commentary on Assurant's recent earnings beat and valuation narrative.

Company-level read

Ticker impact

$AIZBullishMedium confidence
Context

Assurant raised its full-year earnings outlook after a Q2 2026 earnings beat.

Expected impact

Small upside over the next few weeks if market digests the raised guidance.

Evidence & confidence

Guidance upgrades typically support price, but the article provides no new quantitative detail.

Market effects

Highlights continued demand for device protection, modestly supportive of the insurance sector.

U.S. insurance market may see slight positive sentiment.

Limited; focus is on a single U.S. insurer.

Counterpoint

The outlook lift may be already priced in; valuation still appears stretched.

Key entities

  • Assurant

    U.S. insurance provider (ticker AIZ).

Related articles

$AIZMedAI 8/10

Do Wall Street Analysts Like Assurant Stock?

Assurant (AIZ) stock has risen 34.7% over the past year, outperforming the S&P 500. Q2 2026 revenue was $3.5B, up 6.9% YoY, with adjusted EPS of $6.41. Analysts expect 11.5% EPS growth for the year. Nine analysts rate it 'Strong Buy,' with a mean price target of $321.43, implying 11.4% upside.

$AIZMedAI 8/10

Assurant (AIZ) Q2 2026 Earnings Call Transcript

Assurant (AIZ) reported Q2 2026 results in an earnings call transcript. Adjusted EBITDA excluding catastrophes rose 18% to $491.4M, and adjusted EPS excluding catastrophes grew 19% to $6.60. Net earned premiums, fees and other income increased 9% to $3.32B. The company revised full-year adjusted EBITDA guidance to mid-single-digit growth and reported $911M liquidity plus $75M Q2 share repurchases.

$AIZMedAI 8/10

Why Assurant (AIZ) Stock Is Trading Up Today

Assurant (AIZ) shares rose about 6.3% after the company reported Q2 2026 results that beat Wall Street. Adjusted EPS was $6.41, above the $5.18 estimate, and up 23.7% year over year. Revenue increased 9.5% to $3.45 billion. Pre-tax margin rose to 10.9%.

$AIZMed

Assurant: Q2 Earnings Snapshot

Assurant Inc. (AIZ) reported Q2 profit of $298.6 million, or $5.95 per share. Adjusted earnings were $6.41 per share versus Zacks’ estimate of $5.16. Revenue was $3.45 billion, with adjusted revenue $3.46 billion versus $3.4 billion expected. Shares were $281.31 at Tuesday’s close.